Neurodegeneration and a New Generation of Discoveries
Wednesday, October 5, 2016
8:30 a.m. – 12 p.m.
Belfer Research Building • Starr-Greenberg Conference Center
Ruben Family Conference Center • 3rd floor
413 East 69th Street • New York City
With scientific presentations by
Samantha Budd Haeberlein, PhD (Biogen)
Advances in Clinical Development of Novel Therapeutics for Alzheimer’s Disease
Jacqueline Burré, PhD (Weill Cornell Medicine)
Function and Dysfunction of alpha-Synuclein – Membranes Matter
David M. Holtzman, MD (Washington University School of Medicine)
The Neurobiology of APOE and Alzheimer’s Disease
Special remarks by
Robert J. Appel (Vice Chair, Board of Overseers)
Gregory Petsko, PhD (Director, Helen and Robert Appel Alzheimer’s Disease Research Institute
Arthur J. Mahon Professor of Neuroscience)
Panel discussion moderated by
Matthew E. Fink, MD (Chairman, Department of Neurology; Louis and Gertrude Feil Professor of Clinical Neurology)
From left to right: Dr. Iadecola, Dr. Holtzman, Dr. Haeberlein, Dr. Choi, Mr. Appel, Dr. Petsko, and Dr. Burré.